In response to Teva cancelling plans to manufacture a generic version of Boniva, a drug for osteoporosis, Roche dropped two law suits with Judge Stanley R. Chesler of the U.S. District Court (New Jersey), putting the final stamp on the without-prejudice dismissals.
Meanwhile,a couple of weeks back, Hoffmann-La Roche Inc. sued Teva Pharmaceuticals USA, Inc. et al. in the same District Court of New Jersey regarding infringement of U.S. Patent No. 5,472,949 following a Paragraph IV certification as part of Teva’s filing of an ANDA to manufacture a generic version of Roche’s Xeloda, used to treat breast, colon and colorectal cancer.
